In addition, our preliminary experiments in a rat model of experimental autoimmune encephalomyelitis (EAE) suggested that the application of both GM-CSF/IL-6- and GM-CSF/IL-6/PGE2-induced bone-marrow cells can suppress the development of EAE symptoms, and the duration of the disease. The gene discussed is IL6; the disease is experimental autoimmune encephalomyelitis.